The master himself Dr. Jacob Møller speaks to us about the trials and tribulations that were necessary to take DanGer Shock across the finish line. He also shares some important insights about use of mAFP in CS. This is a must listen!!
🫀 New Episode | SoCCC Pre-Rounds 11 | Dropping June 5 at 5 PM ET
For over 20 years, cardiogenic shock lacked a major positive randomized trial. DanGer Shock changed that.
Dr. Simon Parlow @sdparlow sits down with Dr. Jacob Møller — critical care cardiologist at University Hospital Copenhagen — to break down what microaxial flow pumps actually do at the bedside, why the DanGer Shock results surprised even the investigators, and how patient selection determines everything.
Key insights from this episode:
→ How these devices unload the left ventricle and reduce myocardial oxygen demand
→ Why only a small fraction of shock patients qualified — and what that means for you
→ Lactate trajectories as a guide to device management
→ Why the weaning window may be earlier than we thought (12–24 hrs)
→ Applying DanGer lessons outside the trial population
"After seeing the results of DanGer, we have probably become a little bit more liberal in using the device in other forms of ischemic shock." — Dr. Jacob Møller
🎧 Listen June 5 at 5 PM ET — join the SoCCC community: https://t.co/jxiGXLfkUD
@CCCEnthusiasts@JasonKatzMD@jameshorowitzmd@AnnGageMD@ElliottMillerMD
Supported by @zoll_cms — keeping high-impact education free.
#CardiogenicShock #CriticalCare #Cardiology #DanGerShock #MedTwitter #CICU #CardiacICU #PodcastForClinicians
The American Heart Association mourns the passing of the legendary cardiologist Eugene Braunwald, M.D., widely recognized as one of the most influential figures in the history of cardiovascular medicine. Over seven decades, his work reshaped the understanding and treatment of heart disease, leading many to call him the father of modern cardiology.
Braunwald was a lifelong contributor to the American Heart Association, helping advance its research and scientific mission, and was honored with some of the Association’s highest honors for his lasting influence on cardiovascular care and research. His influence extended well beyond his own discoveries, as generations of Association‑supported investigators, clinicians and academic leaders were trained by Braunwald or guided by the clinical trial standards and mentorship models he helped establish.
https://t.co/ieZuHYMyOP
🎧 Available Now: SoCCC Pre-Rounds – Episode 9
The POCUS Revolution: Why Echo Belongs in Every ICU
With Dr. Hatem Soliman @EchoSoliman
Hosted by Dr. Simon Parlow @sdparlow
Point-of-care ultrasound is transforming resuscitation and cardiac critical care—and in this episode, we break down how to use it effectively at the bedside.
Join Dr. Simon Parlow and Dr. Hatem Soliman as they explore how critical care echocardiography can identify reversible causes of cardiac arrest, guide CPR, and refine real-time hemodynamic assessment.
🔍 Key takeaways:
• Look beyond the IVC—multi-organ Doppler for venous congestion
• Interpret cardiac output in context, not isolation
• Master high-yield views like the apical 5-chamber & short-axis great vessels
• Recognize common pitfalls in POCUS
If you’re aiming to sharpen your resuscitation and ICU skillset, this episode delivers practical, high-impact insights.
🎙️ Listen now:
https://t.co/81mfDJasx5
@CCCEnthusiasts@JasonKatzMD@ElliottMillerMD@jameshorowitzmd@AnnGageMD
#POCUS #CriticalCare #Cardiology #Echo #MedEd #SoCCC #CardiacICU
In an international, randomized trial involving patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during the 3-month treatment period.
Full COBRRA trial results: https://t.co/tvPYrBCWj8
It is almost November 🫣... which means another SoCCC Pre-Rounds PODCAST will be dropping soon! Next Friday (11/7) you'll get to hear Dr. Anthony Carnicelli chat with @RyanTedfordMD to break down everything you need to know about Right Ventricular Failure! This tricky condition shows up in a bunch of serious illnesses like pulmonary hypertension, left HF, and sepsis. @BalimSenmanMD@JasonKatzMD@AnnGageMD@ElliottMillerMD@jameshorowitzmd@CCCEnthusiasts
At this weekend's #OAAM2025, we honoured one of our best, Dr. Joel Parlow, w/ our Distinguished Service Award.
Dr. Parlow has had a transformative impact on anesthesia care in 🇨🇦 & abroad via his career at @queensu & his time w/ @CAS_IEF
Learn more: https://t.co/wA6qd7utw5
🎙️COMING IN 2 WEEKS🎙️
A new SoCCC Pre-Rounds Podcast: The Basics of ECMO with Jason Katz, MD, MHS, FACC, FAHA (@JasonKatzMD), President of @SocietyOfCCC, and Critical Care Cardiologist, Simon Parlow, MD, FRCPC (@sdparlow).
🗓️Mark your calendars (9/5)! We may just break the internet again…
To listen to Episode 1: VT Storm: https://t.co/mJg6P1LhwI
🚨 IT’S HERE! 🚨
The wait is over...the podcast episode that’s about to break the internet has officially dropped! 🎙
🎧 Listen now: https://t.co/tlkh1b9Can
Join us on Pre-Rounds Podcast hosted by @BalimSenmanMD, as @ElliottMillerMD breaks down VT Storm with life-saving tips for #ICU and #CICU physicians. This is critical care education like you’ve never heard before.
#GreatestPodcastEver #VTStorm #SoCCC #PodcastLaunch #CriticalCare #PreRoundsPodcast
@JasonKatzMD@AnnGageMD@jameshorowitzmd@CCCEnthusiasts
🎉Mark your calendars! Our first SoCCC Pre-Rounds Podcast episode launches August 8th, featuring Drs. Balim Senman (@BalimSenmanMD), Elliott Miller (@ElliottMillerMD), Simon Parlow (@sdparlow), and Anthony Carnicelli (@Carnicelli_Ant). Join us for a powerful conversation packed with insight, experience, and forward-thinking perspectives on the future of critical care cardiology. You won’t want to miss this, it's just the beginning!
Just released! Check out the trailer for our brand new podcast "Pre-Rounds" delivering bite-sized, high-yield episodes designed for medical students, residents, fellows, early-career cardiologists, allied health professionals + all enthusiasts of critical care cardiology navigating the complexities of the field. Episode 1 to be released in August!
https://t.co/JYQtJoBIbr
What are the outcomes of different mechanical circulatory support strategies in infarct-related cardiogenic shock? Check out this #JACCINT sub-analysis of the ECLS-SHOCK trial https://t.co/8gzmx61qAj
#CardiogenicShock#cvMI@feistritzerH_J
Sharing what we hope is an important paper in #SHOCK out today in @NEJMEvidence by @JungRichardG (who just matched to cardiology!).
Prognostic Factors Associated with Mortality in Cardiogenic Shock — A Systematic Review and Meta-Analysis | NEJM Evidence https://t.co/Qm5v2D1Wne
#Cardiogenicshock is associated with high morbidity/mortality but little is known about associated costs. Our analysis of 9,789 AMI-CS patients in Ontario reveals SIGNIFICANT associated cost - both in hospital and post discharge @JACCJournals@rebeccamathewmd@shanfernands
Median one-yr cost of $37,913 USD (3X higher than cost of avg HF and AMI admission in Canada).
Cost was $63,539 for those readmitted to hospital and $77,643 in lowest home time quartile.
Clearly reducing disability and maintaining independence is key for cost-effectiveness!